IP Library › Assignment 062321/0679
Patent Assignment
Reel/Frame 062321/0679

Assignment of Assignor's Interest

Recorded: 2023-01-10 Pages: 8
Assignor
CADENT THERAPEUTICS, INC.
Executed: 2022-12-01
Assignee
NOVARTIS AG
LICHSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property (1)
Purinyl Derivatives and Their Use as Potassium Channel Modulators
Patent: 9,340,544 →
Application: 13/720,956 →
Publication: US 2013/0109704
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 4, 2013
From: ERIKSEN, BIRGITTE L; SORENSEN, ULRIK; HOUGAARD, CHARLOTTE; PETERS, DAN
To: NEUROSEARCH A/S
Reel/Frame 029917/0830 →
Assignment of Assignor's Interest Mar 20, 2013
From: NEUROSEARCH A/S
To: ANIONA APS
Reel/Frame 030049/0894 →
Assignment of Assignor's Interest Aug 6, 2013
From: ANIONA APS
To: ATAXION, INC.
Reel/Frame 030946/0329 →
Merger Dec 20, 2022
From: ATAXION, INC.
To: LUC THERAPEUTICS, INC.
Reel/Frame 062155/0043 →
Change of Name Jan 3, 2023
From: LUC THERAPEUTICS, INC.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 062265/0889 →